Skip to content

Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction

Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction (ARISTOTLE)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06069232
Acronym
ARISTOTLE
Enrollment
2000
Registered
2023-10-05
Start date
2021-03-01
Completion date
2028-03-01
Last updated
2023-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Disease

Keywords

aortic stenosis, aortic valve insufficiency, risk factor, prediction model

Brief summary

This study is a multicenter cohort study including patients diagnosed with aortic valve disease during hospitalization, including aortic insufficiency and aortic valve stenosis. The primary outcome of the study was all-cause death, and the secondary outcome was cardiovascular events. Through follow-up observation, the prognostic risk factors of patients with aortic disease were evaluated, and a prognostic model was constructed to guide clinical decision-making.

Interventions

None listed

Sponsors

First Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Third Affiliated Hospital, Sun Yat-Sen University
CollaboratorOTHER
Affiliated Hospital of Guangdong Medical University
CollaboratorOTHER
Second Affiliated Hospital of Shantou University Medical College
CollaboratorOTHER
Eighth Affiliated Hospital, Sun Yat-sen University
CollaboratorOTHER
Zhongshan People's Hospital, Guangdong, China
CollaboratorOTHER
Jieyang People's Hospital
CollaboratorOTHER
Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years

Inclusion criteria

* age ≥ 18 * diagnosed as aortic valve disease

Exclusion criteria

* aortic valve replacement at baseline

Design outcomes

Primary

MeasureTime frameDescription
all-cause mortalityfrom baseline to death or end of follow-updeath caused by any cause

Secondary

MeasureTime frameDescription
Cardiovascular deathfrom baseline to death or end of follow-upDeath caused by cardiac causes
Aortic valve replacementfrom baseline to aortic valve replacementTranscatheter aortic valve replacement or surgical aortic valve replacement

Countries

China

Contacts

Primary Contactxiaodong zhuang, PhD
zhuangxd3@mail.sysu.edu.cn+86 13760755035

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026